Gilead Sciences, Inc. (GILD) stock
GILDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 11/30104% above fair value
$168.08+0.13 (+0.08%)
Close on Nov 13, 2026Market cap $208.48BP/E –Yield 1.88%
Gilead Sciences profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Gilead Sciences's profit margin for the twelve months ending Sep 30, 2026 was -12.5%. For fiscal 2025 it was 28.9%, against 1.7% the year before. The highest annual figure on record is 55.5% in fiscal 2015.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 28.9% | +27.2 |
| FY2024 | Dec 31, 2024 | 1.7% | −19.2 |
| FY2023 | Dec 31, 2023 | 20.9% | +4.1 |
| FY2022 | Dec 31, 2022 | 16.8% | −6.0 |
| FY2021 | Dec 31, 2021 | 22.8% | +22.3 |
| FY2020 | Dec 31, 2020 | 0.5% | −23.5 |
| FY2019 | Dec 31, 2019 | 24.0% | −0.7 |
| FY2018 | Dec 31, 2018 | 24.7% | +6.9 |
| FY2017 | Dec 31, 2017 | 17.7% | −26.7 |
| FY2016 | Dec 31, 2016 | 44.4% | −11.1 |
| FY2015 | Dec 31, 2015 | 55.5% | +6.9 |
| FY2014 | Dec 31, 2014 | 48.6% | +21.2 |
| FY2013 | Dec 31, 2013 | 27.5% | +0.7 |
| FY2012 | Dec 31, 2012 | 26.7% | −6.7 |
| FY2011 | Dec 31, 2011 | 33.4% | −3.1 |
| FY2010 | Dec 31, 2010 | 36.5% | −1.1 |
| FY2009 | Dec 31, 2009 | 37.6% | +0.5 |
| FY2008 | Dec 31, 2008 | 37.1% | −0.4 |
| FY2007 | Dec 31, 2007 | 37.5% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 29.3% | −10.0 |
| Q2 FY2026 | Jun 30, 2026 | -134.5% | −162.2 |
| Q1 FY2026 | Mar 31, 2026 | 29.0% | +9.3 |
| Q4 FY2025 | Dec 31, 2025 | 27.5% | +4.0 |
| Q3 FY2025 | Sep 30, 2025 | 39.3% | +22.7 |
| Q2 FY2025 | Jun 30, 2025 | 27.7% | +4.5 |
| Q1 FY2025 | Mar 31, 2025 | 19.7% | +82.1 |
| Q4 FY2024 | Dec 31, 2024 | 23.6% | +3.5 |
| Q3 FY2024 | Sep 30, 2024 | 16.6% | −14.3 |
| Q2 FY2024 | Jun 30, 2024 | 23.2% | +7.4 |
| Q1 FY2024 | Mar 31, 2024 | -62.4% | −78.3 |
| Q4 FY2023 | Dec 31, 2023 | 20.1% | −2.1 |
| Q3 FY2023 | Sep 30, 2023 | 30.9% | +5.5 |
| Q2 FY2023 | Jun 30, 2023 | 15.8% | −2.4 |
| Q1 FY2023 | Mar 31, 2023 | 15.9% | +15.6 |
| Q4 FY2022 | Dec 31, 2022 | 22.2% | +16.9 |
| Q3 FY2022 | Sep 30, 2022 | 25.4% | −9.5 |
| Q2 FY2022 | Jun 30, 2022 | 18.3% | −6.2 |
| Q1 FY2022 | Mar 31, 2022 | 0.3% | −26.6 |
| Q4 FY2021 | Dec 31, 2021 | 5.3% | −15.6 |
| Q3 FY2021 | Sep 30, 2021 | 34.9% | +29.5 |
| Q2 FY2021 | Jun 30, 2021 | 24.5% | +89.4 |
| Q1 FY2021 | Mar 31, 2021 | 26.9% | −1.0 |
| Q4 FY2020 | Dec 31, 2020 | 20.9% | −25.0 |
| Q3 FY2020 | Sep 30, 2020 | 5.5% | +26.3 |
| Q2 FY2020 | Jun 30, 2020 | -64.9% | −98.0 |
| Q1 FY2020 | Mar 31, 2020 | 28.0% | −9.4 |
| Q4 FY2019 | Dec 31, 2019 | 45.9% | +45.8 |
| Q3 FY2019 | Sep 30, 2019 | -20.8% | −58.3 |
| Q2 FY2019 | Jun 30, 2019 | 33.1% | +0.9 |
| Q1 FY2019 | Mar 31, 2019 | 37.4% | +7.2 |
| Q4 FY2018 | Dec 31, 2018 | 0.1% | +65.0 |
| Q3 FY2018 | Sep 30, 2018 | 37.5% | −4.3 |
| Q2 FY2018 | Jun 30, 2018 | 32.2% | −10.9 |
| Q1 FY2018 | Mar 31, 2018 | 30.2% | −11.3 |
| Q4 FY2017 | Dec 31, 2017 | -65.0% | −107.4 |
| Q3 FY2017 | Sep 30, 2017 | 41.7% | – |
| Q2 FY2017 | Jun 30, 2017 | 43.0% | – |
| Q1 FY2017 | Mar 31, 2017 | 41.5% | – |
| Q4 FY2016 | Dec 31, 2016 | 42.5% | – |
See a number that looks wrong?